The investment intends to bring the startup’s innovative self-driving technology to a wider range of Kia and Hyundai vehicle models.   The Hyundai investment brings the total funding raised by the startup to approximately $70....

Hemispherx Biopharma Inc., a US-based biopharmaceutical company recently announced having treated its first patient with Ampligen in combination with Cisplatin & Pembrolizumab, in a phase 2 ovarian cancer clinical trial. As per credibl....

AirCTO team would be joining Go-Jek immediately and will be looking at building products that speed up recruitment for Go-Jek Go-Jek, the Indonesia-based ride-hailing startup has reportedly acquired AirCTO, an artificial intelligence-power....

The firm’s drug (HMI-102) is expected to be the first gene therapy candidate for phenylketonuria (PKU) to enter clinics. Genetic drug maker, Homology Medicines, Inc. has recently announced the enrollment of its Phase 1/2 pheNIX trial....

Google is investing millions across 14 U.S. states and the investment in Michigan is expected to add a significant number of jobs Google LLC, the multinational technology company, has announced an investment of $17 million in Little Caesar....

Next-generation Guardian CGM is designed to lower sensor calibrations, improve and refine the accuracy and the overall performance of the system World’s largest company for medical devices, Medtronic recently announced that it has st....

The company also has plans to launch a plug and play version of its product by 2020. The India-based Saas startup Dockabl has reportedly announced that it has raised $1.26 million in a pre-series A funding round led by a pool of marquee in....

Series B financing round has brought the total funds raised by AllyO to $64 million California based AllyO, an eminent developer of AI driven job hiring products, recently announced the conclusion of its series B financing round where it r....

Cellenkos Inc., an early stage clinical biotechnology company recently announced initiation of Phase 1 clinical trial of CK0801 for treatment of bone marrow failure syndromes, including primary myelofibrosis, hypoplastic myelodysplasia &....

The French multinational pharmaceutical company Sanofi has reportedly announced crucial Phase 3 ICARIA-MM trial results which revealed that isatuximab aided with dexamethasone and pomalidomide (isatuximab combination therapy) has shown stat....